Just days after announcing a crackdown on researchers who do not disclose drug company ties, the editor of a prestigious medical journal says she was misled again this time by the authors of a study linking severe migraines to heart attacks in women.

All six study authors have done consulting work or received research funding from makers of treatments for migraines or heart-related problems. Their research appears in Wednesday’s Journal of the American Medical Association, a week after the crackdown was announced.

The authors said they did not report their financial ties because they did not believe they were relevant to the study.

Dr. Catherine DeAngelis, JAMA’s editor in chief, said journal editors did not know about the ties until The Associated Press brought them to her attention late last week.

“We’ll get killed,” she said, referring to the potential damage to the journal’s reputation.

She said she would have published the authors’ associations with drug makers had she known about them. “Let me decide what’s pertinent or not,” DeAngelis said. “The issue is not what can those companies possibly gain; it is the issue of perception.”

This Week's Circulars

Recommended for you